LXEO
USDLexeo Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$8.300
Máximo
$8.355
Mínimo
$7.660
Volumen
2.85M
Fundamentos de la Empresa
Capitalización de Mercado
597.8M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.04M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.